A. Denisova, A. B. Malahov, A. Pampura, Elena V. Vishneva, M. Soloshenko, Nikoloz M. Gaboshvili, L. S. Namazova-Baranova
Background. The emergence of new functional capabilities of statistical accounting made it possible to conduct a comparative analysis of the morbidity of allergic pathologies according to the registers of allergists and pediatricians from the Unified Medical Information and Analytical System (UMIAS) of Moscow with data from the Form of Federal Statistical Observation No. 12 (FSO No. 12). The aim of the study is to investigate the potential of using UMIAS for assessing/monitoring the morbidity of allergic diseases, including bronchial asthma in children, using the example of several outpatient clinics (OPCs) in Moscow. Methods. A study of combined design has been carried out. The data of children of several OPCs in Moscow were analyzed — data from UMIAS (observation registers of pediatricians and allergist-immunologists) and from the reporting forms of the FSO No. 12. Results. For a comparative analysis of statistical data from UMIAS and FSO No. 12, we studied the information of 60,851 children under 18 years of age. It was revealed that out of 60,851 children: allergic rhinitis according to FSO No. 12 and UMIAS was established in 1001 and 1059 patients; atopic dermatitis — in 142 and 345; urticaria — in 363 and 33; angioedema — in 4 and 16, respectively; food allergy — in 233 children according (to FSO No. 12) and in none of the children (according to UMIAS). Out of 60,851 children, 619 children were diagnosed with bronchial asthma according to the annual report (FSO No. 12) and 537 according to the pediatrician’s observation registers (UMIAS). At the same time, it was found that the diagnosis of bronchial asthma is not available as a separate nosology in the registry of an allergist-immunologist, and information about children with bronchial asthma is available to this specialist only when analyzing the uploaded information about children with other allergic diseases. Conclusion. A adequate sample ensured a high representativeness of the results obtained. The differences in the incidence rates of allergic diseases revealed by a comparative analysis of data from various sources — UMIAS and FSO No. 12 — indicate the need to improve both the system of statistical registration of incidence and the development of modern algorithms for early diagnosis and dynamic monitoring of children with allergies.
{"title":"Features of Statistical Accounting of Allergic Diseases in Children — Evidence from Moscow","authors":"A. Denisova, A. B. Malahov, A. Pampura, Elena V. Vishneva, M. Soloshenko, Nikoloz M. Gaboshvili, L. S. Namazova-Baranova","doi":"10.15690/pf.v20i5.2633","DOIUrl":"https://doi.org/10.15690/pf.v20i5.2633","url":null,"abstract":"Background. The emergence of new functional capabilities of statistical accounting made it possible to conduct a comparative analysis of the morbidity of allergic pathologies according to the registers of allergists and pediatricians from the Unified Medical Information and Analytical System (UMIAS) of Moscow with data from the Form of Federal Statistical Observation No. 12 (FSO No. 12). The aim of the study is to investigate the potential of using UMIAS for assessing/monitoring the morbidity of allergic diseases, including bronchial asthma in children, using the example of several outpatient clinics (OPCs) in Moscow. Methods. A study of combined design has been carried out. The data of children of several OPCs in Moscow were analyzed — data from UMIAS (observation registers of pediatricians and allergist-immunologists) and from the reporting forms of the FSO No. 12. Results. For a comparative analysis of statistical data from UMIAS and FSO No. 12, we studied the information of 60,851 children under 18 years of age. It was revealed that out of 60,851 children: allergic rhinitis according to FSO No. 12 and UMIAS was established in 1001 and 1059 patients; atopic dermatitis — in 142 and 345; urticaria — in 363 and 33; angioedema — in 4 and 16, respectively; food allergy — in 233 children according (to FSO No. 12) and in none of the children (according to UMIAS). Out of 60,851 children, 619 children were diagnosed with bronchial asthma according to the annual report (FSO No. 12) and 537 according to the pediatrician’s observation registers (UMIAS). At the same time, it was found that the diagnosis of bronchial asthma is not available as a separate nosology in the registry of an allergist-immunologist, and information about children with bronchial asthma is available to this specialist only when analyzing the uploaded information about children with other allergic diseases. Conclusion. A adequate sample ensured a high representativeness of the results obtained. The differences in the incidence rates of allergic diseases revealed by a comparative analysis of data from various sources — UMIAS and FSO No. 12 — indicate the need to improve both the system of statistical registration of incidence and the development of modern algorithms for early diagnosis and dynamic monitoring of children with allergies.","PeriodicalId":19997,"journal":{"name":"Pediatric pharmacology","volume":"37 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139268037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Shilova, Zajnab G. Alieva, O. Bashkina, B. Kantemirova
The scientific review of the literature provides information on current clinical observations of the use of proton pump inhibitors in large randomized trials of Russian and foreign scientists, issues of their classification, pharmacokinetics, pharmacodynamics, pharmacogenetics, efficacy and safety of prescribing in pediatric practice, due to the growth of acid-dependent conditions in children and the need for further systematic research with the development of approaches to personalization of prescribing drugs for each age group.
{"title":"Proton pump inhibitors in pediatric practice","authors":"A. Shilova, Zajnab G. Alieva, O. Bashkina, B. Kantemirova","doi":"10.15690/pf.v20i5.2606","DOIUrl":"https://doi.org/10.15690/pf.v20i5.2606","url":null,"abstract":"The scientific review of the literature provides information on current clinical observations of the use of proton pump inhibitors in large randomized trials of Russian and foreign scientists, issues of their classification, pharmacokinetics, pharmacodynamics, pharmacogenetics, efficacy and safety of prescribing in pediatric practice, due to the growth of acid-dependent conditions in children and the need for further systematic research with the development of approaches to personalization of prescribing drugs for each age group.","PeriodicalId":19997,"journal":{"name":"Pediatric pharmacology","volume":"86 1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139323747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
I. Anisimova, M. Albegova, M. Bagaeva, G. Baidakova, A. A. Baranov, N. Vashakmadze, E. Vishneva, O. Gundobina, A. Degtiareva, M. Ezhov, M. Zharkova, N. V. Zhurkova, E. Zaharova, V. Ivashkin, E. Kamenets, S. I. Kutzev, A. E. Lavrova, Irina A. Matinian, S. Mikhailova, L. Namazova-Baranova, I. Pashkova, E. Petriaykina, T. Pervunina, Nataliia L. Pechatnikova, Nelia S. Pogosian, S. Repina, L. Selimzianova, T. Skvortsova, T. Strokova, Dmitriy M. Subbotin, A. Surkov, E. Tumanova, Ekaterina G. Tzimbalova
Lysosomal acid lipase deficiency is s a rare hereditary enzymopathy. The article presents epidemiological data and features of etiopathogenesis of two phenotypic forms of lysosomal acid lipase deficiency — Wolman disease and cholesterol ester storage disease. Special attention has been given to the key issues of differential diagnostic search, clinical guidelines based on the principles of evidence-based medicine have been given.
{"title":"Clinical guidelines for the management of children with lysosomal acid lipase deficiency","authors":"I. Anisimova, M. Albegova, M. Bagaeva, G. Baidakova, A. A. Baranov, N. Vashakmadze, E. Vishneva, O. Gundobina, A. Degtiareva, M. Ezhov, M. Zharkova, N. V. Zhurkova, E. Zaharova, V. Ivashkin, E. Kamenets, S. I. Kutzev, A. E. Lavrova, Irina A. Matinian, S. Mikhailova, L. Namazova-Baranova, I. Pashkova, E. Petriaykina, T. Pervunina, Nataliia L. Pechatnikova, Nelia S. Pogosian, S. Repina, L. Selimzianova, T. Skvortsova, T. Strokova, Dmitriy M. Subbotin, A. Surkov, E. Tumanova, Ekaterina G. Tzimbalova","doi":"10.15690/pf.v20i4.2602","DOIUrl":"https://doi.org/10.15690/pf.v20i4.2602","url":null,"abstract":"Lysosomal acid lipase deficiency is s a rare hereditary enzymopathy. The article presents epidemiological data and features of etiopathogenesis of two phenotypic forms of lysosomal acid lipase deficiency — Wolman disease and cholesterol ester storage disease. Special attention has been given to the key issues of differential diagnostic search, clinical guidelines based on the principles of evidence-based medicine have been given.","PeriodicalId":19997,"journal":{"name":"Pediatric pharmacology","volume":"154 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86166980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The prevalence of inflammatory bowel diseases (IBD) is increasing worldwide. Crohn's disease (CD) and ulcerative colitis (UC) are characterized by chronic progressive course, high frequency of complications, and high risk of surgical treatment. Up to 50% of CD patients die due to its complications, and quarter of these patients require at least one surgery during their lifetime. IBD patients have 8 times higher risk of colorectal and small intestine cancer. IBD diagnosis can be established during childhood in 25% of cases. Early intensified therapy of individual patient groups could significantly reduce complications and surgical treatment rates. However, nowadays there are no reliable prognostic criteria for the unfavorable course of IBD. The aim of this review is to define the most studied IBD serological markers and to evaluate immune reactivation role in CD and UC course in children.
{"title":"Clinical and Diagnostic Value of Inflammatory Bowel Diseases' Serological Markers in Children (Literature Review)","authors":"A. Kamalova, Marina A. Khanafina, G. A. Garina","doi":"10.15690/pf.v20i4.2605","DOIUrl":"https://doi.org/10.15690/pf.v20i4.2605","url":null,"abstract":"The prevalence of inflammatory bowel diseases (IBD) is increasing worldwide. Crohn's disease (CD) and ulcerative colitis (UC) are characterized by chronic progressive course, high frequency of complications, and high risk of surgical treatment. Up to 50% of CD patients die due to its complications, and quarter of these patients require at least one surgery during their lifetime. IBD patients have 8 times higher risk of colorectal and small intestine cancer. IBD diagnosis can be established during childhood in 25% of cases. Early intensified therapy of individual patient groups could significantly reduce complications and surgical treatment rates. However, nowadays there are no reliable prognostic criteria for the unfavorable course of IBD. The aim of this review is to define the most studied IBD serological markers and to evaluate immune reactivation role in CD and UC course in children.","PeriodicalId":19997,"journal":{"name":"Pediatric pharmacology","volume":"9 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79597749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Vyacheslav V. Yazev, D. Rusinova, Alexey S. Bezymyanniy
Integration of the International Classification of Functioning, Disability and Health into the real practice of medical and social rehabilitation institutions is one of the tasks of the World Health Organization. Thus, collection of data on disability via this classification, creation of software and mobile applications for its implementation in practice will improve rehabilitation's quality and accessibility. In general, it is crucial for creation of scientific framework for health indicators and treatment outcomes assessment; for creation of common language to describe health indicators to improve understanding between health professionals, researchers, and people with disabilities; for providing information to rehabilitation-related professionals in different countries; for providing coding scheme for health information systems (including children and adolescents).
{"title":"Literature Review on the Application of International Classification of Functioning, Disability and Health for Children and Adolescents around the World and in Russian Federation","authors":"Vyacheslav V. Yazev, D. Rusinova, Alexey S. Bezymyanniy","doi":"10.15690/pf.v20i4.2586","DOIUrl":"https://doi.org/10.15690/pf.v20i4.2586","url":null,"abstract":"Integration of the International Classification of Functioning, Disability and Health into the real practice of medical and social rehabilitation institutions is one of the tasks of the World Health Organization. Thus, collection of data on disability via this classification, creation of software and mobile applications for its implementation in practice will improve rehabilitation's quality and accessibility. In general, it is crucial for creation of scientific framework for health indicators and treatment outcomes assessment; for creation of common language to describe health indicators to improve understanding between health professionals, researchers, and people with disabilities; for providing information to rehabilitation-related professionals in different countries; for providing coding scheme for health information systems (including children and adolescents).","PeriodicalId":19997,"journal":{"name":"Pediatric pharmacology","volume":"72 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77870795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background. Ichthyosis is a group of rare genetic diseases with a wide phenotypic spectrum, characterized most often by generalized hyperkeratinization and desquamation with variable erythema [1]. In most cases, the diagnosis is established immediately after birth on the basis of clinical data. The basis of treatment is correct skin care, regular moisturizing, prevention of infection. Case Reports. The article describes clinical cases of congenital ichthyosis in two boys from the same family born 8 years apart. At the time of birth, both children had similar clinical signs and the disease progression types. Conclusion. Children in this family showed a genetically similar form of congenital ichthyosis. Due to timely initiation of complex treatment and correct skin care, there was a significant favourable evolution.
{"title":"Clinical observation of familial cases of congenital ichthyosis","authors":"Nailya R. Pimenova, E. Kashirskaya, A. Alekseeva","doi":"10.15690/pf.v20i4.2604","DOIUrl":"https://doi.org/10.15690/pf.v20i4.2604","url":null,"abstract":"Background. Ichthyosis is a group of rare genetic diseases with a wide phenotypic spectrum, characterized most often by generalized hyperkeratinization and desquamation with variable erythema [1]. In most cases, the diagnosis is established immediately after birth on the basis of clinical data. The basis of treatment is correct skin care, regular moisturizing, prevention of infection. Case Reports. The article describes clinical cases of congenital ichthyosis in two boys from the same family born 8 years apart. At the time of birth, both children had similar clinical signs and the disease progression types. Conclusion. Children in this family showed a genetically similar form of congenital ichthyosis. Due to timely initiation of complex treatment and correct skin care, there was a significant favourable evolution.","PeriodicalId":19997,"journal":{"name":"Pediatric pharmacology","volume":"80 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82587143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. Shervashidze, D. S. Smirnova, T. T. Valiev, K. Kirgizov, S. Varfolomeeva
Glucocorticoids (GC) are used as anti-inflammatory, immunosupressive and anti-tumor agents for several decades due to their ability to cell cycle inhibition and apoptosis induction but mechanism of action is not fully explored. Glucocorticoids play one of the key roles in acute lymphoblastic leukaemia treatment and are at the forefront in induction and reinduction phases. The response of tumor clone to GC determines a risk group and prognosis. A number of mechanisms of antileukemic action and resistance factors will be describe in this article.
{"title":"Antileukemic impact of glucocorticoid use in acute lymphoblastic leukaemia treatment","authors":"M. Shervashidze, D. S. Smirnova, T. T. Valiev, K. Kirgizov, S. Varfolomeeva","doi":"10.15690/pf.v20i4.2603","DOIUrl":"https://doi.org/10.15690/pf.v20i4.2603","url":null,"abstract":"Glucocorticoids (GC) are used as anti-inflammatory, immunosupressive and anti-tumor agents for several decades due to their ability to cell cycle inhibition and apoptosis induction but mechanism of action is not fully explored. Glucocorticoids play one of the key roles in acute lymphoblastic leukaemia treatment and are at the forefront in induction and reinduction phases. The response of tumor clone to GC determines a risk group and prognosis. A number of mechanisms of antileukemic action and resistance factors will be describe in this article.","PeriodicalId":19997,"journal":{"name":"Pediatric pharmacology","volume":"23 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78638762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. A. Baranov, T. T. Batysheva, O. Bykova, N. Vashakmadze, E. Vislobokova, A. Vitebskaya, E. Vishneva, Victoria Yu. Voynova, N. Zhurkova, E. Zakharova, L. Kiselnikova, M. Kostik, S. Kutsev, T. Margieva, L. Namazova-Baranova, S. Mikhaylova, S. Moiseev, Tatyana S. Nagornaya, L. Selimzyanova, A. Semyachkina, Olga Ya. Smirnova, M. Fedoseenko, Svetlana V. Pishchal'nikova
Hypophosphatasia is rare genetic disease caused by tissue-nonspecific alkaline phosphatase deficiency due to the mutation in the ALPL gene. Disease can manifest in utero, in childhood or in adults depending on its form and severity. This article presents modern data on the epidemiology, etiology, and clinical signs of hypophosphatasia in children, covers in details differential diagnostic search, and gives guidelines for its evidence-based treatment. Without timely treatment the prognosis of the disease is unfavorable in most cases. Such patients require follow-up by multidisciplinary team of physicians. The only effective method of treatment is enzyme replacement therapy with asfotase alfa. Symptomatic therapy is also crucial as well as physiotherapeutic procedures and therapeutic exercise programs (at rehabilitation stage).
{"title":"Modern Approaches to the Management of Children with Hypophosphatasia","authors":"A. A. Baranov, T. T. Batysheva, O. Bykova, N. Vashakmadze, E. Vislobokova, A. Vitebskaya, E. Vishneva, Victoria Yu. Voynova, N. Zhurkova, E. Zakharova, L. Kiselnikova, M. Kostik, S. Kutsev, T. Margieva, L. Namazova-Baranova, S. Mikhaylova, S. Moiseev, Tatyana S. Nagornaya, L. Selimzyanova, A. Semyachkina, Olga Ya. Smirnova, M. Fedoseenko, Svetlana V. Pishchal'nikova","doi":"10.15690/pf.v20i4.2601","DOIUrl":"https://doi.org/10.15690/pf.v20i4.2601","url":null,"abstract":"Hypophosphatasia is rare genetic disease caused by tissue-nonspecific alkaline phosphatase deficiency due to the mutation in the ALPL gene. Disease can manifest in utero, in childhood or in adults depending on its form and severity. This article presents modern data on the epidemiology, etiology, and clinical signs of hypophosphatasia in children, covers in details differential diagnostic search, and gives guidelines for its evidence-based treatment. Without timely treatment the prognosis of the disease is unfavorable in most cases. Such patients require follow-up by multidisciplinary team of physicians. The only effective method of treatment is enzyme replacement therapy with asfotase alfa. Symptomatic therapy is also crucial as well as physiotherapeutic procedures and therapeutic exercise programs (at rehabilitation stage).","PeriodicalId":19997,"journal":{"name":"Pediatric pharmacology","volume":"33 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79342384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Профилактика инфекционных заболеваний является одним из приоритетов в сфере охраны здоровья (Федеральный закон от 21 ноября 2011 г. № 323-ФЗ «Об основах охраны здоровья граждан в Российской Федерации» (действующая редакция, 2016 г.).
{"title":"Resolution of the independent expert council of the union of experts in the field of immunoprophylaxis","authors":"A. Editorial","doi":"10.15690/pf.v20i4.2608","DOIUrl":"https://doi.org/10.15690/pf.v20i4.2608","url":null,"abstract":"Профилактика инфекционных заболеваний является одним из приоритетов в сфере охраны здоровья (Федеральный закон от 21 ноября 2011 г. № 323-ФЗ «Об основах охраны здоровья граждан в Российской Федерации» (действующая редакция, 2016 г.). ","PeriodicalId":19997,"journal":{"name":"Pediatric pharmacology","volume":"82 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77311697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
3-5 марта 2023 г. в г. Москве c огромным успехом прошел XXIV Конгресс педиатров России с международным участием «Актуальные проблемы педиатрии», посвященный 150-летию со дня рождения выдающегося отечественного педиатра Г.Н. Сперанского. В рамках Конгресса состоялся уже ставший традицией Конкурс научных работ молодых ученых, в котором принял участие 51 человек (студенты, ординаторы, аспиранты, ассистенты, научные сотрудники, врачи) из 15 городов России (всего подано 42 заявки). Представляем вашему вниманию тезисы, поступившие от молодых ученых в оргкомитет Конгресса, в том числе занявшие призовые места.
{"title":"Abstracts of the young scientists competition","authors":"A. Editorial","doi":"10.15690/pf.v20i4.2581","DOIUrl":"https://doi.org/10.15690/pf.v20i4.2581","url":null,"abstract":"3-5 марта 2023 г. в г. Москве c огромным успехом прошел XXIV Конгресс педиатров России с международным участием «Актуальные проблемы педиатрии», посвященный 150-летию со дня рождения выдающегося отечественного педиатра Г.Н. Сперанского. В рамках Конгресса состоялся уже ставший традицией Конкурс научных работ молодых ученых, в котором принял участие 51 человек (студенты, ординаторы, аспиранты, ассистенты, научные сотрудники, врачи) из 15 городов России (всего подано 42 заявки). Представляем вашему вниманию тезисы, поступившие от молодых ученых в оргкомитет Конгресса, в том числе занявшие призовые места.","PeriodicalId":19997,"journal":{"name":"Pediatric pharmacology","volume":"114 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77566673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：